DMD market expected to grow to $5.2bn in the 7MM by 2033
The Duchenne muscular dystrophy (DMD) landscape across the seven major markets (7MM) - the US, France, Germany, Italy, Spain, ...
Dyne Therapeutics Announces Upcoming Presentations at the 2025 MDA Clinical & Scientific Conference
Data from DELIVER and ACHIEVE Clinicals Trial to be Presented - - Presentation on ACHIEVE Trial in DM1 and Company Symposium to Feature Data on the Use of Splicing Correction as a Prognostic Biomarker ...
The Pharma Letter4h
DMD market set for strong growth in coming years
The Duchenne muscular dystrophy (DMD) market is projected to grow from $2.3 billion in 2023 to $5.2 billion in 2033 across ...
Exxon consolidates Proxxima operations in Baytown, continues growth
Exxon spent the past year moving a lab's operations from California to Baytown and plans to increase its number of employees ...
eLife22h
Afadin-deficient retinas exhibit severe neuronal lamination defects but preserve visual functions
However, the study provides limited new insights into the relationship between retinal lamination defects and overall retinal function. Neural lamination is a common feature of the central nervous ...